Our Transactions
Leadership across the largest and most complex situations
Lead Financial Advisor
on its pending €8.0 billion
acquisition of
from Vodafone Group
2024
Exclusive Financial Advisor
on its pending ~$2.3 billion
acquisition of
2024
Independent Financial Advisor
on its pending acquisition of three fill-finish sites for an upfront payment of $11 billion from Novo Holdings following its $16.5 billion acquisition of Catalent
2024
Exclusive Financial Advisor
on its pending ~$35 billion
acquisition of
2024
Exclusive Financial Advisor
on its pending ~$12.6 billion
sale to
2024
Lead Financial Advisor
on its pending $11.5 billion
all-stock merger with
2024
Lead Financial Advisor
on its pending ~$13.4 billion
sale to
2023
Financial Advisor
on its pending ~$14.9 billion
sale to
2023
Financial Advisor
on its pending $60 billion
all-stock acquisition of
2023
Financial Advisor
on its up to $5.8 billion
acquisition of
2023
Financial Advisor
on its pending ~$20 billion
merger with
2023
Lead Left Bookrunner
$300 million
Follow-on Offering
2023
Exclusive Financial Advisor
on its chapter 11 restructuring of ~$1.9 billion of debt and $125 million DIP ABL financing
2023
Active Bookrunner
$1.1 billion IPO & $1.6 billion
Follow-on Offering
2023
Exclusive Financial Advisor
on its pre-packaged chapter 11 restructuring of ~$3.6 billion of debt and preferred equity
2023
Lead Financial Advisor
on its ~$36 billion
spin-off of
2021
Anouncement Date1
Status
Transaction
Value (M)
February 2, 2024
Closed
Acted as an Active Bookrunner on Vaxcyte’s Follow-on Offering
$863
February 1, 2024
Closed
Acted as an Active Bookrunner on Fractyl Health's initial public offering
$110
January 31, 2024
Closed
Acted as a Joint Bookrunner on Amer Sports’ Initial Public Offering
$1,570
January 30, 2024
Closed
Acted as an Active Bookrunner on Astria Therapeutics' Underwritten Equity Offering
$125
January 30, 2024
Pending
Advising Amphenol on its acquisition of the Carlisle Interconnect Technologies business of Carlisle
$2,025
January 29, 2024
Closed
Acted as an Active Bookrunner on Vera Therapeutics' Follow-on Offering
$288
January 25, 2024
Closed
Acted as Exclusive Global Placement Agent for the fundraise of Arlington Capital Partners Fund VI
$3,810
January 22, 2024
Pending
Advising Hg Capital on its minority stake sale in Argus Media to General Atlantic
N/A
January 22, 2024
Closed
Acted as a Placement Agent on Dianthus Therapeutics’ Private Placement Financing
$230
January 18, 2024
Pending
Advising Panera on the sale of Caribou Coffee’s CPG Business to JDE Peet’s
$260
1Announcement date for M&A transactions represents the date publicly announced; announcement date for restructurings represents the date publicly announced or filed; announcement date for capital markets transactions represents the pricing date.